21.8 C
New York
Wednesday, June 10, 2026

Tag: IT

Canada launches mission to combat illegal, unreported and unregulated fishing in the North Pacific Ocean

OTTAWA, ON, June 9, 2026 /CNW/ - Illegal, unreported, and unregulated (IUU) fishing threatens national and international fish stocks and the broader ocean ecosystem....

HyOrc Corporation Retains Stonegate Capital Partners to Lead Investor Outreach and Support Nasdaq Uplisting Strategy

HyOrc Corporation Retains Stonegate Capital Partners to Lead Investor Outreach and Support Nasdaq Uplisting Strategy

KENCO STEPS-UP AS ‘OFFICIAL SPONSOR OF STAYING AWAKE’ AS SCHEDULE REVEALS SUMMER MATCH TIMES WILL PUSH EUROPEAN FOOTBALL FANS TO THE LIMIT

Published match timings show Central European fans face 71 late-night kick-offs (68.3% of the tournament).UK fans face 60 late-night matches (57.7%), while Eastern European...

1911 Gold Announces Voluntary Withdrawal of Overnight Marketed Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./VANCOUVER, BC, June 9, 2026 /CNW/ - 1911 Gold Corporation...

DeployAIBots Establishes Miami Headquarters, Expanding AI-Driven Automation for Growing Businesses

Joel Yi

Company builds agentic AI operating systems that replace repetitive work and enable teams to scale faster with fewer resources

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to lasmecabtagene timgedleucel (lasme-cel), its CD22-targeting allogeneic CAR-T cell therapy product candidate, for the treatment of patients with relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL).

Cummings Properties Highlights Important Criteria for the Best Companies to Lease Commercial Space From in Bedford, MA

Massachusetts-based Cummings Properties shares insights on selecting top commercial real estate firms.
Massachusetts-based Cummings Properties shares insights on selecting top commercial real estate firms.

Flex to Join S&P 500 Index

Milestone reflects company's transformation and consistent performanceAUSTIN, Texas, June 9, 2026 /PRNewswire/ -- Flex (NASDAQ: FLEX) today announced it has been selected to join the...

Cereals Canada Launches the 2026 Growing Season Progress Report

WINNIPEG, MB, June 10, 2026 /PRNewswire/ -- With Canada's 2026 spring wheat crop underway, Cereals Canada has resumed regular updates to its interactive Growing...

Automated People Mover Market to Reach USD 4.86 Billion by 2032 – Credence Research

LONDON, June 9, 2026 /PRNewswire/ -- The "Automated People Mover Market – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032" report has been added...

Slutty Vegan Brings Its Mission Closer to the Community, Announces New Baltimore Location

Beloved Plant-Based Brand Charts its Next Chapter in Founder Pinky Cole Hayes' HometownATLANTA, June 9, 2026 /PRNewswire/ -- Slutty Vegan, the nationally recognized plant-based...

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026

The Annual General Meeting of Hofseth BioCare ASA for 2026 will be held at the company's premises at Keiser Wilhelms gate 24, 6003 Ålesund, on 30 June 2026 at 11:00 CEST.

MEXC prediction markets launches combo to enable multi-event combination trading

MUTSAMUDU, Comoros, June 09, 2026 (GLOBE NEWSWIRE) -- MEXC has officially launched Combo, a new feature within its prediction markets ecosystem, in partnership with its collaborators. This marks the first time a centralized platform has introduced multi-event combination trading capabilities to prediction markets globally, through its partner.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsIT